AstraZeneca, FibroGen’s roxadustat hits snag at FDA, but analysts figure an approval’s still on its way esagonowsky Mon, 12/21/2020 – 09:33 More: AstraZeneca, FibroGen's roxadustat hits snag at FDA, but analysts figure an approval's still on its way Source: fierce
read moreTreatment demonstrated non-inferior visual acuity gains compared to Regeneron’s Eylea More: Roche’s faricimab hits the mark in diabetic macular edema study Source: News
read moreDrug becomes first treatment for peanut allergy in the EU More: Aimmune’s peanut allergy med Palforzia wins EU approval Source: News
read moreCompany will immediately begin delivering doses to the US government More: US approves Moderna’s COVID-19 vaccine for emergency use Source: News
read moreEGFR-TKI approved in the US for early non-small cell lung cancer More: Green light for AZ’s Tagrisso in early-stage lung cancer Source: News
read moreModerna scores FDA authorization for its COVID-19 vaccine, adding key 2nd shot as nationwide campaign ramps up esagonowsky Fri, 12/18/2020 – 10:51 More: Moderna scores FDA authorization for its COVID-19 vaccine, adding key 2nd shot as nationwide campaign ramps up
read more© 1994 - 2026 B.M. Pharmaceuticals